Michele Splinter to Clinical Trials as Topic
This is a "connection" page, showing publications Michele Splinter has written about Clinical Trials as Topic.
Connection Strength
0.062
-
Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome. Ann Pharmacother. 2007 Feb; 41(2):285-95.
Score: 0.062
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.